Boston Scientific (BSX) Research & Development (2009 - 2026)

Boston Scientific has disclosed Research & Development across 18 years of filings, most recently posting $516.0 million for Q1 2026.

• Research & Development for Q1 2026 came in at $516.0 million, up 16.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 25.59% YoY), and the FY2025 annual result was $2.1 billion, up 27.06% from the prior year.
• Research & Development came in at $516.0 million for Q1 2026 at Boston Scientific, down from $569.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $569.0 million in Q4 2025 to a low of $319.0 million in Q1 2022.
• The 5-year median for Research & Development is $366.0 million (2024), against an average of $407.1 million.
• Across the five-year window, Research & Development advanced 3.12% in 2022 and soared 37.34% in 2025, its largest moves.
• Boston Scientific's Research & Development stood at $330.0 million in 2022, then gained by 10.0% to $363.0 million in 2023, then advanced by 26.45% to $459.0 million in 2024, then advanced by 23.97% to $569.0 million in 2025, then fell by 9.31% to $516.0 million in 2026.
• The last three Research & Development figures came in at $516.0 million (Q1 2026), $569.0 million (Q4 2025), and $514.0 million (Q3 2025), per Business Quant data.